Sirtris Pharmaceuticals said that it's CEO, Christoph Westphal, has been named the Ernst & Young New England Entrepreneur of the Year in the biopharmaceutical field.
Westphal is a co-founder of Alnylam Pharmaceuticals, and previously was a partner at Alnylam investor Polaris Venture Partners.
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
